CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

T. Rowe Price Investment Management, Inc.'s Holding History (CIK: 0001897612)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 29,085 Value ($000) $1 Avg Close $44.52 Range $38.81 - $50.98
Q3 2025
Shares 60,584 Value ($000) $3 Avg Close $31.97 Range $25.83 - $47.41
Q2 2025
Shares 716,172 Value ($000) $21 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 689,265 Value ($000) $23 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 1,002,882 Value ($000) $51 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 1,068,532 Value ($000) $55 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 1,347,210 Value ($000) $60 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 2,654,729 Value ($000) $124 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 2,417,493 Value ($000) $86 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 1,640,692 Value ($000) $49 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 964,005 Value ($000) $17 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 929,369 Value ($000) $15 Avg Close $18.51 Range $15.23 - $21.65